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PICTORIAL ESSAY
ABSTRACT 
Primary lymphomas of the female genital tract are extreme-
ly rare, and a definitive diagnosis requires correlation of the 
clinical, radiological, and pathological findings. Unlike non-
lymphomatous malignant tumors, the treatment of lym-
phoma is typically nonsurgical, thus raising the possibility of 
lymphoma in the differential diagnosis of a pelvic mass, a 
radiologist can significantly change the approach to the dis-
ease. Although some imaging findings may appear nonspe-
cific, others may suggest the possibility of lymphoma, such 
as the presence of one or more solid, well-defined, homo-
geneous masses without necrosis despite a large size or the 
presence of diffuse infiltration leading to organomegaly with 
architectural preservation. Additionally, pelvic lymphadenop-
athy may be evident. In this pictorial essay, we discuss the ra-
diological appearances of gynecological primary lymphomas, 
grouped by organ, in ultrasonography, computed tomogra-
phy, and magnetic resonance imaging.
L ymphomas of the female genital tract are uncommon. Most of them are secondary tumors (primary tumors are very rare), with a few case reports in the literature. Lymphomas can be classified as 
non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL), which 
show different imaging patterns. In contrast to  Hodgkin lymphoma, 
extranodal  involvement is more frequent in non-Hodgkin lymphoma 
as well as dissemination to noncontiguous nodes with involvement of 
different nodal groups (1, 2). Extranodal lymphoma is classified as pri-
mary or secondary. Primary lymphoma refers to the following: 1) lym-
phomatous involvement confined to a solitary extranodal site and its 
immediately adjacent lymph node group or contiguous structures at the 
time of diagnosis; 2) the absence of abnormal cells in the peripheral 
blood and bone marrow; and 3) the absence of further lymphomatous 
lesions at remote sites after several months (3).
Clinical staging is based on a combination of clinical, radiologic, 
and surgical findings, following the Ann Arbor staging system (Table) 
(4). Currently recommended approaches for staging consist of routine 
physical examination, laboratory analysis, chest X-ray, cross-sectional 
imaging of the chest, abdomen, and pelvis, bone marrow biopsy, and 
lumbar puncture (in selected cases of NHL) for any stage beyond clinical 
stage IA. Fluorine-18 fluorodeoxyglucose positron emission tomography 
(18F-FDG PET) is included in the most recent recommendations for pre-
treatment evaluation, particularly in the setting of equivocal results (4). 
The presenting symptoms of primary lymphomas of the female gen-
ital tract depend on the site involved and the aggressiveness of the tu-
mor. These include vaginal bleeding, vaginal discharge, an abdominal 
mass, dispareunia, perineal discomfort, urinary retention, or constitu-
tional symptoms (5–7). The prognosis varies according to the stage and 
histological subtype (4).
Imaging techniques
A definitive diagnosis requires a biopsy (bone marrow, lymph node, 
or mass), but imaging plays an important role in the noninvasive man-
agement of lymphomas, including the establishment of a provisional 
diagnosis, staging of disease, and follow-up. Complications of both the 
disease and treatment may be also recognized.
Ultrasonography (US) can be useful in the initial investigation of pri-
mary lymphomas of the female genital tract, but computed tomography 
(CT) and magnetic resonance imaging (MRI) are better for assessing the 
lesion size, structure, and extension to adjacent structures. MRI also pro-
vides greater accuracy in the characterization of pelvic tumors. The role 
of lymphangiography has been superseded by these techniques (1, 8).
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Gallium-67 (67Ga) scintigraphy, 
18F-FDG PET, and PET-CT are valuable 
for the identification of disease in nor-
mal-sized organs, the differentiation 
of post-treatment fibrosis and residual 
viable tumor, detection of early recur-
rence, prediction of an early response 
to chemotherapy, and determination 
of prognosis (2, 9). Advantages of PET 
over 67Ga scintigraphy are higher accu-
racy, better spatial resolution, same day 
imaging, and a lower radiation dose (2). 
The selection of appropriate imaging 
modalities is complex and depends on 
the patient, radiologist, and institu-
tional constraints.
Imaging features
Generally, the pattern of lympho-
matous involvement may be nodular, 
multinodular, or diffuse. Regarding the 
first two disease patterns, solid, round, 
well-defined, homogeneous lesions are 
present with a minimal mass effect for 
their size. Necrosis, hemorrhage, and 
calcification are rare in the absence of 
treatment. In diffuse disease, there is 
uniform infiltration of the parenchyma, 
producing organomegaly without struc-
tural abnormalities. In the latter case, 
the organ contour usually is normal or 
slightly abnormal, even in advanced 
disease (2, 3, 6, 7, 10). Pelvic lymphade-
nopathy may also be evident (5).
In the reported cases, on US, lym-
phomas tend to appear hypoechoic, 
with an absence of posterior acoustic 
enhancement and showing mild vas-
cularization on color Doppler US. On 
CT, lymphomas show a density similar 
to that of muscle or moderated hypoat-
tenuation when compared with the 
surrounding parenchyma, but usually 
have attenuation values higher than 
water. On MRI, lymphomas usually 
exhibit low-to-intermediate signal in-
tensity on T1-weighted imaging and 
moderately high signal intensity on 
T2-weighted imaging (2, 3, 6, 7, 10, 11). 
Enhancement after the administra-
tion of intravenous contrast material 
tends to be mild and uniform. How-
ever, in some cases, contrast-enhanced 
images may depict subtle heteroge-
neous areas that are not visible on 
unenhanced images. Rarely, central 
necrosis and hemorrhage may produce 
a heterogeneous appearance on unen-
hanced or contrast-enhanced images 
(2, 6, 7, 10, 12). 
On PET, a standardized uptake value 
greater than 2.5 suggests malignancy (5).
Ovarian lymphomas
The age range of patients diagnosed 
with ovarian lymphoma is from 18 
months to 74 years (5).
Unilateral and bilateral ovarian in-
volvement shows a similar incidence 
(5). The lesions are frequently larger, 
and ascites is infrequent (12). Peritone-
al involvement is evident in less than 
half of cases (5). Extraovarian extension 
occurs most commonly through the 
pelvic and para-aortic lymph nodes (5).
The presence of septal structures 
showing hyperintensity on T2-weight-
ed imaging, and a linear arrangement 
of small cysts at the periphery of tumor 
was reported (Fig. 1) (11).
The differential diagnosis of ovarian 
primary lymphoma is usually made 
with ovarian epithelial neoplasms 
(which normally have a complex 
structure with cystic/necrotic areas 
and solid components with early en-
hancement), sarcomas (which are less 
likely to be bilateral), and other pre-
dominantly solid ovarian tumors such 
as fibromas, thecomas, and Brenner 
cell tumors that have low growth rates. 
Additionally, in children, germ cell tu-
mors and neuroblastomas usually have 
an inhomogeneous structure. Metasta-
ses should be considered if a primary 
lesion or other sites of metastases are 
observed (3). A concurrent finding of 
adenopathy can help the diagnosis.
Lymphomas of the uterus body 
and cervix
The median age at diagnosis is in the 
fourth to fifth decades (5, 7). Most pri-
mary uterine lymphomas arise from the 
cervix; however, in most cases, both the 
Table. Ann Arbor system for staging of lymphoma (4) 
Stage Description
I Involvement of a single lymph node region or lymphoid structure (e.g., the spleen, thymus, Waldeyer’s ring) or involvement of a single  
 extralymphatic site (IE)
II  Involvement of more than one lymphatic region on only one side of the diaphragm
 IIE Localized involvement of one extralymphatic organ or site and its regional lymph nodes with or without other nodes on  
  the same side of the diaphragm
 IIS Involvement of more than one lymphatic region on only one side of the diaphragm plus involvement of the spleen
 IIES Both
III Involvement of lymph node regions on both sides of the diaphragm
 IIIE Involvement of lymph node regions on both sides of the diaphragm plus localized involvement of an extra lymphatic  
  organ or site
 IIIS  Involvement of lymph node regions on both sides of the diaphragm plus involvement of the spleen
 IIIES  Both
IV Diffuse or disseminated involvement of one or more extralymphatic organs or tissues with or without associated lymph node  
 enlargement. Organs considered distant include the liver, bone, bone marrow, lung and/or pleura, and kidney
Suffices to each stage: 
A, without symptoms—e.g., stage IA or IIIA. 
B, with symptoms (night sweats, unexplained fever >38°C, and unexplained weight loss >10% within the last six months)—e.g., stage IIB or IVB.
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cervix and uterine body are involved 
(5). Symmetrical diffuse uterine en-
largement is the most common appear-
ance (Fig. 2), but it may seem as a large 
lobulated mass or as multiples nodules. 
These lesions have also been described 
as a submucosal mass mimicking a leio-
myoma. Usually, the endometrium and 
cervical epithelium are not involved 
(7). Bladder and vaginal invasion may 
be seen (Fig. 3) (6, 7). Significant en-
hancement with gadolinium was re-
ported, a finding that is slightly unusu-
al compared with lymphoma in solid 
abdominal organs (2). 
The differential diagnosis includes 
cervical carcinoma, small-cell carcino-
ma of the uterus, metastases, and sarco-
ma (5). Architectural preservation and 
sparing of the uterine junctional and 
inner layer of the cervical stroma, de-
spite the extensive involvement of the 
uterine body, may suggest the diagno-
sis of lymphoma (6). In cases affecting 
the mucosa, it is difficult to differen-
tiate lymphoma from the much more 
common epithelial neoplasms. In 
these cases, the presence of a relatively 
homogeneous tumor, despite the larg-
er tumor size, may be helpful for diag-
nosis. Apparent septations postintra-
venous contrast enhancement, leading 
to a nodular appearance, was suggested 
as another evocative finding (7).
Lymphomas of the vagina
The mean age at diagnosis is 50 years 
(5). The tumor may be infiltrative or 
lobular (Fig. 4). The infiltrative form is 
more common and appears as diffuse 
thickening of the vaginal wall (Fig. 5) 
(10). Contiguous spread of the tumor 
into the cervix may be observed (10).
The differential diagnosis of prima-
ry lymphoma of the vagina is made 
with other more common vaginal neo-
plasms, such as carcinoma. An intact 
mucosa is distinctive of lymphoma (10).
Lymphomas of the endometrium
Primary endometrial lymphoma is 
particularly rare and may appear as dif-
fuse thickening of the endometrium 
without myometrial involvement or 
as a polypoid lesion with or without 
a diffuse coating of the endometrium 
(Fig. 6) (13). Endometrial hyperplasia, 
endometrial polyps, and carcinoma can 
have similar morphologic aspects and 
must be considered in the differential 
diagnosis.
Lymphomas of the fallopian tubes
Only rare cases of primary tubal lym-
phoma have been reported; most cases 
of fallopian tube involvement reflect 
more extensive disease arising in the 
ovary. No study has described in detail 
the imaging findings.
Figure 1. a–d. A 23-year-old female with bilateral primary B-cell non-Hodgkin lymphoma of 
the ovaries. The patient was human immunodeficiency virus positive and presented with an 
abdominal mass. Coronal (a) and axial (b) fast spin-echo T2-weighted MRI showed a solid, 
lobulated, large, bilateral adnexal mass with intermediate signal intensity and hyperintense 
septal structures, some small cysts with smooth walls, consistent with follicles at the periphery 
of the tumor (a, arrows). Only a small amount of ascites was observed (b, asterisk). On axial 
spin-echo T1-weighted MRI (c), the tumor demonstrated low signal intensity, and a follicle was 
observed (arrow). On axial contrast-enhanced fat-saturated T1-weighted MRI (d), the septa 
showed marked enhancement (arrowheads) compared with the slight enhancement observed 
in the other solid portion.
a
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Figure 2. a, b. A 47-year-old female with primary lymphoma of the uterine body and cervix. The 
patient presented with hydronephrosis on routine US, and a pelvic mass was noted at physical 
examination. Axial (a) and sagittal (b) unenhanced CT of the pelvis and abdomen denoted a 
diffuse, homogeneous enlargement of the uterine body and cervix (asterisk) that did not show a 
cleavage plane with the bladder. Additionally, pelvic lymphadenopathy was observed in the right 
external iliac and inguinal chains (a, arrow). A biopsy of the cervix revealed diffuse, large B-cell 
non-Hodgkin lymphoma. 
a b
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The age of presentation is in the third 
to fifth decades (14, 15). Lymphoma-
tous involvement may be unilateral or 
bilateral (14, 15), having been associ-
ated with chronic inflammation (tu-
bo-ovarian abscess or endometriosis) 
in some cases (15). In some reported 
cases, the patients presented with a 
complex pelvic mass; in other cases, 
lymphoma was found as an incidental 
finding during pelvic surgery (14, 15).
A differential diagnosis includes in-
flammatory pelvic disease, carcinoma, 
and metastases (15).
Residual disease
A commonly encountered problem 
on follow-up is distinguishing between 
fibrosis/residual nonviable tissue after 
therapy and residual disease.
In MRI, reducing the signal intensity 
on T2-weighted imaging is associat-
ed with reducing the cellular density 
and successful treatment (10). Fibrot-
ic tissue produces very low signal in-
tensity on T2-weighted imaging and 
no enhancement with gadolinium. 
In the early stages of fibrosis and in 
inflammatory changes induced by 
radiotherapy, the signal intensity on 
T2- weighted imaging may be inter-
mediate or high, but shows absence 
of restriction on (low signal intensity) 
diffusion-weighted images.
18F-FDG PET can also detect very 
small foci of disease in residual mass-
es (2), but inflammatory changes from 
recent surgery and radiation thera-
py have also demonstrated increased 
18F-FDG uptake (9).
Figure 3. a–g. A 25-year-old female with primary lymphoma of the cervix and vagina. The 
patient had a history of genital human papilloma virus infection and presented with vaginal 
bleeding and a vaginal fetid discharge. Axial contrast-enhanced CT of the pelvis (a, b) showed 
a homogeneous, lobulated mass of the vagina with uniform enhancement that invaded the 
posterior pelvic wall (a, white arrow) and vulva (b, asterisk). Pelvic lymphadenopathy was 
observed in the left external obturator chain (a, black arrow). Sagittal fast spin-echo T2-
weighted MRI (c) showed a moderately hyperintense lobulated tumor involving the vaginal 
wall and uterine cervix (arrow) and extending down into the perineum. Although the mass was 
very large, the cervical epithelium remained as a hyperintense band anteriorly to the tumor (c, 
arrow). Axial fast spin-echo T2-weighted MRI (d) showed invasion of the vulva (asterisks). Axial 
spin-echo T1-weighted MRI (e) showed that the tumor had low signal intensity and that pelvic 
lymphadenopathy was evident (arrow). Sagittal diffusion-weighted images (f, g) acquired 
at a b value of 600 s/mm2 demonstrated high signal intensity of the mass (f, asterisk) and a 
low apparent diffusion coefficient on a corresponding apparent diffusion coefficient map (g, 
asterisk). A biopsy of the tumor revealed diffuse large B-cell non-Hodgkin lymphoma.
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Figure 4. A 64-year-old female with primary 
lymphoma of the vagina. The patient 
presented with vaginal bleeding. Axial 
unenhanced CT of the pelvis showed a 
solid, well-defined, homogeneous, isodense 
mass of the vagina (asterisk). A biopsy of 
the vagina revealed B-cell non-Hodgkin 
lymphoma.
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Conclusion
Lymphoma is a diagnostic chal-
lenge, particularly in the context of 
a newly discovered pelvic mass. De-
spite the absence of specific imaging 
patterns, there are radiologic appear-
ances that must alert the radiologist 
about the possibility of primary lym-
phomas of the female genital tract. 
Familiarity with these appearances 
may allow the radiologist to offer an 
accurate differential diagnosis, avoid-
ing unnecessary surgical interven-
tions and the associated morbidity 
and mortality. 
Figure 6. a–f. A 71-year-old female with primary lymphoma of the endometrium. She presented with vaginal bleeding and a pelvic mass. Axial 
unenhanced CT of the pelvis (a, b) showed homogeneous enlargement of the uterine body (a, asterisk) and a pelvic isodense mass extending 
to the parametrium, invading the posterior pelvic wall (b, thick arrow), encasing the pelvic ureter (b, arrowhead) and causing hydronephrosis. 
Enlarged locoregional lymph nodes were identified (a, b, thin arrows). Sagittal fast spin-echo T2-weighted (c) MRI showed a moderately 
hyperintense polypoid tumor of the endometrium (asterisk), extending anteriorly and inferiorly and involving the myometrium, cervix, anterior 
vaginal wall, and bladder wall (arrow). The cervical epithelium was spared. Axial spin-echo T1-weighted MRI (d) showed that the tumor had 
intermediate signal intensity with an enlarged pelvic ureter showing low signal intensity (arrow). Enlarged locoregional lymph nodes are shown 
(arrowheads). On axial contrast-enhanced fat-saturated T1-weighted MRI (e), the tumor showed uniform mild enhancement. Axial diffusion-
weighted images acquired at a b value of 600 s/mm2 (f) showed high signal intensity of the mass (asterisk). A biopsy of the tumor revealed 
diffuse non-Hodgkin lymphoma.
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Figure 5. a–c. A 32-year-old female with primary lymphoma of the vagina. The patient presented with vaginal bleeding. Sagittal fast spin-echo 
T2-weighted MRI (a) showed a slightly hyperintense infiltrating tumor, resulting in a diffuse thickening of the vaginal wall extending to cervix. 
Note the presence of intact mucosa (arrow). A submucosal fibroid was also observed in the mid-uterine body. On axial spin-echo T1-weighted 
MRI (b), the tumor showed low signal intensity. On sagittal contrast-enhanced fat-saturated T1-weighted MRI (c), the tumor showed uniform 
enhancement. No enlarged locoregional lymph nodes were identified. A biopsy of the vagina revealed diffuse large B-cell non-Hodgkin 
lymphoma, and a biopsy of the cervix was negative.
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